Skip to main content

Table 2 Univariate and multivariate logistic regression analysis of risk factors

From: The values of applying classification and counts of white blood cells to the prognostic evaluation of resectable gastric cancers

Risk Factors Overall Survival (OS)
Univariate analysis Multivariate analysis
OR (95% CI) P value OR (95% CI) P value
Gender
 (Female or Male) 0.714 (0.457–1.115) 0.139
Age
 (>  60 years or ≤ 60 years) 1.015 (0.992–1.038) 0.192
Tumor size (cm)
 (>  5 or ≤ 5) 0.848 (0.538–1.337) 0.478
Depth of invasion 2.062 (0.745–5.705) 0.164
 (T3–4 or T1–2)     
Lymphonodus metastasis
 (N2 or N0–1) 2.116 (1.316–3.403) 0.002** 0.544 (0.166–1.777) 0.313
AJCC stage
 (III orI-II) 2.764 (1.641–4.657) 0.000** 4.199 (1.237–14.24) 0.021*
Pre-treatment LY
 (>  1.535 × 109/L or ≤ 1.535 × 109/L) 1.474 (0.987–2.200) 0.058
Pre-treatment MO
 (> 0.330 × 109/L or ≤ 0.330 × 109/L) 1.067 (0.722–1.576) 0.745
Pre-treatment NE
 (>  3.325 × 109/L or ≤ 3.325 × 109/L) 1.585 (1.060–2.371) 0.025* 0.868 (0.522–1.444) 0.586
Pre-treatment EO
 (> 0.090 × 109/L or ≤ 0.090 × 109/L) 0.924 (0.618–1.382) 0.702
Pre-treatment BA
 (> 0.010 × 109/L or ≤ 0.010 × 109/L) 1.151(0.775–1.709) 0.486
Pre-treatment total WBC
 (>  5.361 × 109/L or ≤ 5.361 × 109/L) 2.023 (1.329–3.081) 0.001** 1.751 (1.045–2.935) 0.033*
Post/pre-treatment LY ratio
 (>  1 or ≤ 1) 0.839 (0.563–1.249) 0.387
Post/pre-treatment MO ratio
 (>  1 or ≤ 1) 1.036 (0.703–1.527) 0.860
Post/pre-treatment NE ratio
 (>  1 or ≤ 1) 0.871 (0.571–1.329) 0.521
Post/pre-treatment EO ratio
 (>  1 or ≤ 1) 1.180 (0.796–1.748) 0.410
Post/pre-treatment BA ratio
 (>  1 or ≤ 1) 1.006 (0.638–1.585) 0.980
Post/pre-treatment total WBC ratio
 (>  1 or ≤ 1) 0.766 (0.508–1.154) 0.202
  1. *P<0.05; **P<0.01